logo

1.71

1.71 (-1.37%)

As of Mar 06, 2024

Adaptimmune Therapeutics Plc [ADAP]

Source: 

Company Overview

Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company focused on providing novel cell therapies to people with cancer. We are a leader in the development of T-cell therapies for solid tumors and have seen responses in six solid tumors in clinical trials.

CountryUnited States
Headquartersabingdon, oxfordshire
Phone Number44 1235 430000
Industry
manufacturing
CEOAdrian Rawcliffe
Websitewww.adaptimmune.com